Celebrex is protected by a patent that prevents any generic versions from being manufactured until 2014. However, once the patent expires on brand-name Celebrex, a generic version will likely be made. Sometimes, people confuse the primary ingredient in a drug with a generic version. Celecoxib, for example, is not a generic version of Celebrex -- it's the active ingredient in it.
An Introduction to Generic Celebrex
Celebrex® (celecoxib) is a prescription medicine that is licensed to treat pain and inflammation associated with various conditions, such as arthritis or general muscle pain. The medication is manufactured by Pfizer, and is currently protected by a patent that prevents any generic Celebrex from being manufactured.
When Will There Be a Generic Version?
The first patent for Celebrex expires in May 2014. It was initially expected to expire in 2013, but Pfizer was granted an extension to perform much-needed studies in children. May 2014 is now the earliest predictable date that a generic version of Celebrex could become available. However, other circumstances could extend or shorten this period, such as lawsuits or other patents for specific uses.
Once the patent expires, several companies may begin manufacturing a generic Celebrex drug.
Is Celecoxib a Generic Celebrex?
No -- celecoxib is the active ingredient in Celebrex, but is not a generic version of it. This can be confusing, because the active ingredient of any drug is often referred to as the "generic name." But the generic name is not the same as a generic version of a medicine.
For there to be a generic version, the original medicine must first go off-patent and another company besides the original manufacturer must start making the product.
Written by/reviewed by: Kristi Monson, PharmD;Arthur Schoenstadt, MD
Last reviewed by: KristiMonson, PharmD;
List of references (click here):
Celebrex [package insert]. New York, NY: Pfizer, Inc.;2011 January.
Food and Drug Administration, Center for Drug Evaluation and Research. Electronic orange book: approved drug products with therapeutic equivalence evaluations. FDA Web site. Available at: http://www.fda.gov/cder/ob/. Accessed January 20, 2009.
eMedTV serves only as an informational resource. This site does not dispense medical advice or advice of any kind.
Site users seeking medical advice about their specific situation should consult with their own physician. Click